Home › Funds › C WorldWide Group Holding A/S › VRTX

C WorldWide Group Holding A/S position in VRTX

VERTEX PHARMACEUTICALS INC · Health Care

C WorldWide Group Holding A/S reported holding 46,057 shares of VRTX (VERTEX PHARMACEUTICALS INC) in its Q3 2026 13F filing — a position valued at US$24.1M, representing 0.61% of its reported portfolio and ranking #27 among its reported holdings. C WorldWide Group Holding A/S has disclosed VRTX holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)46.06K sh
Reported value held$24.08M
Portfolio Weight0.61%
First reportedQ3 2023
Last changeHold
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How C WorldWide Group Holding A/S's VRTX position evolved

C WorldWide Group Holding A/S first disclosed a stake in VRTX in Q3 2023 at 93,557 shares (US$32.5M). The position peaked in Q2 2024 at 71,557 shares, worth US$33.5M. Across 13 filings, C WorldWide Group Holding A/S increased the stake 0 time(s), trimmed it 4 time(s) and left it unchanged 8 time(s). The most recent filing (Q3 2026) shows 46,057 shares valued at US$24.1M.

Quarter by quarter

QuarterSharesValueChange
Q3 2023 93.56K $32.53M New
Q4 2023 71.56K $29.12M Reduce
Q1 2024 71.56K $29.91M Hold
Q2 2024 71.56K $33.54M Hold
Q3 2024 67.56K $31.42M Reduce
Q4 2024 67.56K $27.20M Hold
Q1 2025 54.06K $26.21M Reduce
Q2 2025 46.06K $20.50M Reduce
Q3 2025 46.06K $18.04M Hold
Q4 2025 46.06K $20.88M Hold
Q1 2026 46.06K $20.57M Hold
Q2 2026 46.06K $22.88M Hold
Q3 2026 46.06K $24.08M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About VRTX and 13F data

VRTX (VERTEX PHARMACEUTICALS INC) is a Health Care company. 32 other funds we track also report a position in VRTX — the largest reported positions include Capital World Investors (US$13.58B), Capital World Investors (US$12.97B), Capital Research Global Investors (US$9.68B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding VRTX

All VRTX fund holders →

FAQ

How long has C WorldWide Group Holding A/S held VRTX?

C WorldWide Group Holding A/S has disclosed VRTX holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is C WorldWide Group Holding A/S's current position in VRTX?

As of Q3 2026, C WorldWide Group Holding A/S holds 46.06K shares of VRTX (VERTEX PHARMACEUTICALS INC), valued at $24.08M, representing 0.61% of its reported portfolio and ranking #27.

Has C WorldWide Group Holding A/S been buying or selling VRTX?

In the latest 13F filing (Q3 2026), C WorldWide Group Holding A/S held unchanged its position in VRTX. The position peaked in Q2 2024 at 71.56K shares.

Which other funds hold VRTX?

Other major institutional holders of VRTX include Capital World Investors, Capital World Investors, Capital Research Global Investors, among 32 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.